Knut Eis

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT

2-Methyl-Quinazolines

2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH

2-METHYL-QUINAZOLINES

4H-pyrrolo[3,2-c]pyridin-4-one derivatives

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

Compounds, compositions and methods for cancer patient stratification and cancer treatment

4,5-annulated 1,2,4-triazolones

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

2-(morpholin-4-yl)-1,7-naphthyridines

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

Macrocyclic indole derivatives

Compounds, compositions and methods for cancer treatment

4,5-annulated 1,2,4-triazolones

Compounds, compositions and methods for cancer patient stratification and cancer treatment

Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases

Heteroarylbenzimidazole compounds

2-(morpholin-4-yl)-1,7-naphthyridines

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

6-HYDROXYBENZOFURANYL- AND 6-ALKOXYBENZOFURANYL-SUBSTITUTED IMIDAZOPYRIDAZINES

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

2-(morpholin-4-yl)-1,7-naphthyridines

SUBSTITUTED TETRAHYDROPYRIDOTHIENOPYRIMIDINES

3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones

Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders

Amido-substituted azole compounds

2-(morpholin-4-yl)-1,7-naphthyridines

3-HETEROARYL SUBSTITUTED INDAZOLES

Amidoimidazopyridazines as MKNK-1 kinase inhibitors

Aminoimidazopyridazines

Substituted benzothienopyrimidines

Thienopyrimidines

Amino-substituted imidazopyridazines

Amino-substituted imidazopyridazines

Heterocyclyl aminoimidazopyridazines

Amino-substituted imidazopyridazines

Substituted benzylpyrazoles

Amino-substituted imidazopyridazines

AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES AS MKNK1 KINASE INHIBITORS

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

Substituted imidazopyridazines

Substituted aminoimidazopyridazines

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment

CYCLIC KETO-ENOLS FOR THERAPY

CYCLIC KETOENOLS FOR THERAPY

SUBSTITUTED AMIDO PHENOXYBENZAMIDES

METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG

Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors

Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals

SUBSTITUTED ACETAMIDES AS MODULATORS OF THE EP2 RECEPTOR

ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR

Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them

Quinoline derivatives, their preparation, their use, and medicaments comprising them

Quinazoline derivatives, their preparation, their use, and medicaments comprising them

INHIBITORS OF SOLUBLE ADENYLATE CYCLASE

Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments

Thiazolidinones, their production and use as pharmaceutical agents

Metasubstituted thiazolidinones, their manufacture and use as a drug

Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

Thiazolidinones, their production and use as pharmaceutical agents

Thiazolidinones and the use therof as polo-like kinase inhibitors

Inhibitors of soluble adenylate cyclase